6.
Brauchi S, Orta G, Salazar M, Rosenmann E, Latorre R
. A hot-sensing cold receptor: C-terminal domain determines thermosensation in transient receptor potential channels. J Neurosci. 2006; 26(18):4835-40.
PMC: 6674176.
DOI: 10.1523/JNEUROSCI.5080-05.2006.
View
7.
Zhang K, Julius D, Cheng Y
. Structural snapshots of TRPV1 reveal mechanism of polymodal functionality. Cell. 2021; 184(20):5138-5150.e12.
PMC: 8488022.
DOI: 10.1016/j.cell.2021.08.012.
View
8.
Quiding H, Jonzon B, Svensson O, Webster L, Reimfelt A, Karin A
. TRPV1 antagonistic analgesic effect: a randomized study of AZD1386 in pain after third molar extraction. Pain. 2013; 154(6):808-12.
DOI: 10.1016/j.pain.2013.02.004.
View
9.
Garami A, Steiner A, Pakai E, Wanner S, Almeida M, Keringer P
. The neural pathway of the hyperthermic response to antagonists of the transient receptor potential vanilloid-1 channel. Temperature (Austin). 2023; 10(1):136-154.
PMC: 10177699.
DOI: 10.1080/23328940.2023.2171671.
View
10.
Oh U, Hwang S, Kim D
. Capsaicin activates a nonselective cation channel in cultured neonatal rat dorsal root ganglion neurons. J Neurosci. 1996; 16(5):1659-67.
PMC: 6578684.
View
11.
Ujisawa T, Sasajima S, Kashio M, Tominaga M
. Thermal gradient ring reveals different temperature-dependent behaviors in mice lacking thermosensitive TRP channels. J Physiol Sci. 2022; 72(1):11.
PMC: 10717490.
DOI: 10.1186/s12576-022-00835-3.
View
12.
Garami A, Pakai E, McDonald H, Reilly R, Gomtsyan A, Corrigan J
. TRPV1 antagonists that cause hypothermia, instead of hyperthermia, in rodents: Compounds' pharmacological profiles, in vivo targets, thermoeffectors recruited and implications for drug development. Acta Physiol (Oxf). 2018; 223(3):e13038.
PMC: 6032921.
DOI: 10.1111/apha.13038.
View
13.
Gavva N, Treanor J, Garami A, Fang L, Surapaneni S, Akrami A
. Pharmacological blockade of the vanilloid receptor TRPV1 elicits marked hyperthermia in humans. Pain. 2008; 136(1-2):202-10.
DOI: 10.1016/j.pain.2008.01.024.
View
14.
Manitpisitkul P, Brandt M, Flores C, Kenigs V, Moyer J, Romano G
. TRPV1 antagonist JNJ-39439335 (mavatrep) demonstrates proof of pharmacology in healthy men: a first-in-human, double-blind, placebo-controlled, randomized, sequential group study. Pain Rep. 2018; 1(4):e576.
PMC: 5741288.
DOI: 10.1097/PR9.0000000000000576.
View
15.
Nguyen T, Chapman S, Kashio M, Saito C, Strom T, Yasui M
. Single amino acids set apparent temperature thresholds for heat-evoked activation of mosquito transient receptor potential channel TRPA1. J Biol Chem. 2022; 298(9):102271.
PMC: 9396403.
DOI: 10.1016/j.jbc.2022.102271.
View
16.
Vlachova V, Teisinger J, Susankova K, Lyfenko A, Ettrich R, Vyklicky L
. Functional role of C-terminal cytoplasmic tail of rat vanilloid receptor 1. J Neurosci. 2003; 23(4):1340-50.
PMC: 6742269.
View
17.
Yue W, Yuan L, Braz J, Basbaum A, Julius D
. TRPV1 drugs alter core body temperature via central projections of primary afferent sensory neurons. Elife. 2022; 11.
PMC: 9377796.
DOI: 10.7554/eLife.80139.
View
18.
Katz B, Zaguri R, Edvardson S, Maayan C, Elpeleg O, Lev S
. Nociception and pain in humans lacking a functional TRPV1 channel. J Clin Invest. 2022; 133(3).
PMC: 9888381.
DOI: 10.1172/JCI153558.
View
19.
Gao Y, Cao E, Julius D, Cheng Y
. TRPV1 structures in nanodiscs reveal mechanisms of ligand and lipid action. Nature. 2016; 534(7607):347-51.
PMC: 4911334.
DOI: 10.1038/nature17964.
View
20.
Huang Y, Ma J, Bian Y, Bai Q, Gao Y, Di S
. TRPV1 analgesics disturb core body temperature via a biased allosteric mechanism involving conformations distinct from that for nociception. Neuron. 2024; 112(11):1815-1831.e4.
DOI: 10.1016/j.neuron.2024.02.016.
View